RXI PHARMACEUTICALS CORPORATION

Address

1500 West Park Drive
Suite 210
Westborough, MA, 01581-

Information

DUNS: 932221729
# of Employees: 0

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Development of sd-rxRNAs as Therapy for Retinoblastoma and Other Malignancies

    Amount: $292,272.00

    DESCRIPTION (provided by applicant): The study of retinoblastoma, a childhood tumor, has provided numerous insights into cancer biology. Perhaps most significantly, this work has revealed that cancers ...

    SBIRPhase I2012Department of Health and Human Services
  2. Improving self delivering properties of RNAi compounds through medicinal chemistr

    Amount: $273,824.00

    DESCRIPTION (provided by applicant): Introduction of small interfering RNAs (siRNAs) into cells with transfection reagents results in potent and specific gene silencing by RNA interference (RNAi). Unf ...

    SBIRPhase I2011Department of Health and Human Services
  3. Novel RNAi therapy for ALS and other Neurodegenerative Disorders

    Amount: $304,559.00

    DESCRIPTION (provided by applicant): Project Summary / Abstract Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting motor neurons in the central nervous syste ...

    SBIRPhase I2011Department of Health and Human Services
  4. Orally administered anti-TNFalpha RNAi therapeutic for autoimmune disorders

    Amount: $597,088.00

    DESCRIPTION (provided by applicant): Introduction of small interfering RNAs (siRNAs) into cells results in potent and specific gene silencing by RNA interference (RNAi). Unfortunately, while siRNA-bas ...

    SBIRPhase I2010Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government